previous compound ID: 486 next compound
InChIKey: DNTGGZPQPQTDQF-XBXARRHUSA-N
SMILES: CCN(C1=CC=CC=C1C)C(=O)/C=C/C

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"JW Hanrahan" "J Liao" "DY Thomas" "SD Macknight" "GW Carlile" "D Rotin" "J Goepp" "R Robert" "E Matthes" "B Kus"

chemical graph of compound 486





CID is 688020
synonyms found at PubChem are:
crotamiton, 483-63-6, N-Ethyl-o-crotonotoluidide, Crotamitone, Eurax, Veteusan, Eurasil, Euraxil, trans-Crotamiton, Crotamitonum, Crotan, Crotonyl-N-ethyl-o-toluidine, Crotalgin, 124236-29-9, Caswell No. 431B, Crotamitonum [INN-Latin], Crotamitex, UNII-2EEH27851Y, o-CROTONOTOLUIDIDE, N-ETHYL-, EINECS 207-596-3, EPA Pesticide Chemical Code 055701, BRN 3275497, N-Ethyl-N-(2-methylphenyl)-2-butenamide, AI3-17732, 2-Butenamide, N-ethyl-N-(2-methylphenyl)-, DNTGGZPQPQTDQF-XBXARRHUSA-N, 2EEH27851Y, (E)-N-Ethyl-N-(o-tolyl)but-2-enamide, N-ethyl-N-(2-methylphenyl)but-2-enamide, (E)-N-ethyl-N-(2-methylphenyl)but-2-enamide, Q-200893, Bestloid, SMR000059145, Crotamiton, (E)-, (2E)-N-ethyl-N-(2-methylphenyl)but-2-enamide, SR-01000759366, N-Crotonyl-N-ethyl-o-toluidine, CHEBI:31439, Crotamiton [INN:BAN:JAN], Crotamiton [USP:INN:BAN:JAN], Eurax (TN), AC1LEL5N, AC1Q2YLR, Prestwick2_000951, Prestwick3_000951, N-Ethyl-o-crotonotoluidine, D0T3NY, G 7857, AC1Q5IA6, N-Ethyl- o-crotonotoluidide, SCHEMBL32934, BSPBio_000942, BSPBio_002722, Crotamiton (JAN/USP/INN), 3-12-00-01856 (Beilstein Handbook Reference), MLS000759489, MLS001424003, MLS002222307, MLS002695895, N-Ethyl-ortho-crotonotoluidide, SPECTRUM1505271, 2-Butenamide, N-ethyl-N-(2-methylphenyl)-, (E)-, 2-Butenamide, N-ethyl-N-(2-methylphenyl)-, (2E)-, BPBio1_001038, component of Eurax (Salt/Mix), CHEMBL1200709, ZINC56427, MolPort-001-794-624, N-Ethyl-o-crotonotoluidide, 97%, HMS1570P04, HMS1922P21, HMS2051E10, HMS2090A10, HMS2093O12, HMS2097P04, HMS2234E16, HMS3714P04, Pharmakon1600-01505271, BCP13315, HY-B1177, NSC78382, CCG-39402, MFCD00026989, NSC-78382, NSC758951, SBB057407, (E)-N-ethyl-N-o-tolylbut-2-enamide, AKOS015892746, CS-4730, N-Ethyl-N-(2-methylphenyl)-butenamide, NC00107, NSC-758951, NCGC00094571-01, NCGC00094571-02, NCGC00094571-03, NCGC00094571-04, NCGC00094571-05, AK307309, AS-11641, BBV-42867418, CC-26001, CPD000059145, LS-55636, SAM001246702, SC-15884, SC-89488, trans-N-Ethyl-N-(o-tolyl)-2-butenamide, ZB001632, SBI-0206763.P001, 2-Butenamide,N-ethyl-N-(2-methylphenyl)-, AB2000238, AB00513973, E0814, N-Ethyl-N-(2-methylphenyl)-2-butenamide #, ST50409628, (E)-N-ethyl-N-(2-methylphenyl)-2-butenamide, D01381, AB00513973-09, AB00513973_10, 483C636, A827519, I04-0177, SR-01000759366-4, SR-01000759366-6, BRD-K13240564-001-01-8, BRD-K57179821-001-05-5, BRD-K57179821-001-08-9, I01-20166, Crotamiton, British Pharmacopoeia (BP) Reference Standard, Crotamiton, European Pharmacopoeia (EP) Reference Standard, UNII-D6S4O4XD0H component DNTGGZPQPQTDQF-XBXARRHUSA-N, Crotamiton, United States Pharmacopeia (USP) Reference Standard, InChI=1/C13H17NO/c1-4-8-13(15)14(5-2)12-10-7-6-9-11(12)3/h4,6-10H,5H2,1-3H3/b8-4